Van Well Daan 4

What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS (SOPH), sold 2,400 shares in an open-market transaction on April 10, 2026 for a weighted average price of $4.67, generating proceeds of approximately $11,201. The filing indicates these sales were executed to satisfy tax withholding obligations related to restricted stock unit vesting, and were made under a pre-established Rule 10b5-1 trading plan (non-discretionary).

Key Details

• Transaction date: April 10, 2026; Form 4 filed April 14, 2026 (filed 4 days after the trade; later than the typical 2-business-day window).
• Shares sold: 2,400; Weighted average price reported: $4.67; price range across multiple trades: $4.61–$4.77.
• Proceeds: ~$11,201.
• Reason/footnotes: Sales were to satisfy tax withholding on RSU vestings (April 2–3, 2026) and were executed pursuant to a pre-established Rule 10b5-1(c) plan (non-discretionary). The filer can provide per-price sale details on request.
• Shares owned after the transaction: Not specified in the Form 4 filing.

Context
These were routine tax-withholding sales tied to RSU vesting rather than discretionary liquidations; sales under 10b5-1 plans are typically pre-scheduled and do not necessarily signal the insider’s view of the stock. For retail investors, purchases generally carry more informational weight than routine sales for tax purposes.